AstraZeneca Aktie
120,65
EUR
+1,55
EUR
+1,30
%
100,24
GBP
+1,09
GBP
+1,10
%
AstraZeneca Aktie Analyse
| 04.10.12 | AstraZeneca neutral | Exane-BNP Paribas SA | |
| 03.10.12 | AstraZeneca underperform | Credit Suisse Group | |
| 02.10.12 | AstraZeneca hold | Deutsche Bank AG | |
| 26.09.12 | AstraZeneca overweight | Morgan Stanley | |
| 19.09.12 | AstraZeneca buy | UBS AG | |
| 12.09.12 | AstraZeneca underperform | Banc of America Securities-Merrill Lynch | |
| 10.09.12 | AstraZeneca underperform | Banc of America Securities-Merrill Lynch | |
| 04.09.12 | AstraZeneca neutral | Citigroup Corp. | |
|
Werbung
|
|||
| 29.08.12 | AstraZeneca neutral | Goldman Sachs Group Inc. | |
| 29.08.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 29.08.12 | AstraZeneca neutral | Sarasin Research | |
| 28.08.12 | AstraZeneca hold | Deutsche Bank AG | |
| 27.08.12 | AstraZeneca hold | Deutsche Bank AG | |
| 21.08.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 17.08.12 | AstraZeneca underperform | Credit Suisse Group | |
| 16.08.12 | AstraZeneca neutral | Goldman Sachs Group Inc. | |
| 06.08.12 | AstraZeneca verkaufen | Independent Research GmbH | |
| 02.08.12 | AstraZeneca reduce | Nomura | |
| 27.07.12 | AstraZeneca buy | UBS AG | |
| 27.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 19.07.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 18.07.12 | AstraZeneca underperform | Credit Suisse Group | |
| 18.07.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 18.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 18.07.12 | AstraZeneca reduce | Nomura | |
| 16.07.12 | AstraZeneca buy | UBS AG | |
| 12.07.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 03.07.12 | AstraZeneca underperform | Credit Suisse Group | |
| 03.07.12 | AstraZeneca neutral | Banc of America Securities-Merrill Lynch | |
| 03.07.12 | AstraZeneca buy | UBS AG | |
| 03.07.12 | AstraZeneca reduce | Nomura | |
| 02.07.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 02.07.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 02.07.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 28.06.12 | AstraZeneca hold | Deutsche Bank AG | |
| 28.06.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 21.06.12 | AstraZeneca underperform | Credit Suisse Group | |
| 20.06.12 | AstraZeneca neutral | Citigroup Corp. | |
| 19.06.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 15.06.12 | AstraZeneca underperform | Exane-BNP Paribas SA | |
| 11.06.12 | AstraZeneca neutral | J.P. Morgan Cazenove | |
| 08.06.12 | AstraZeneca buy | UBS AG | |
| 05.06.12 | AstraZeneca underperform | Credit Suisse Group | |
| 04.06.12 | AstraZeneca neutral | Citigroup Corp. | |
| 30.05.12 | AstraZeneca hold | Deutsche Bank AG | |
| 28.05.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 18.05.12 | AstraZeneca buy | UBS AG | |
| 10.05.12 | AstraZeneca hold | Société Générale Group S.A. (SG) | |
| 04.05.12 | AstraZeneca buy | UBS AG | |
| 04.05.12 | AstraZeneca verkaufen | Independent Research GmbH | |